NorthWest Biotherapeutics Inc (NWBO)

[Galzus Research]

DCVax was not shown to cure any patients. No response rates were reported in the phase 3 study. Progression-free survival was negative and then abandoned as an endpoint altogether. The only signal seen to date was a small bump in the number of patients surviving overall, which could be an artifact of the external control methodology (seeing curves separate immediately is an unfortunate tell that this could be the case.